Although a number of studies suggest an association between stroke and depression, few have examined the relation between magnetic resonance imaging (MRI)-identified lesions and depression among communitydwelling older adults. This cross-sectional study sought to assess the association between MRI infarcts in the basal ganglia and non-basal-ganglia areas, potential functional consequences of these lesions, and depressive symptomatology in 3,371 US men and women aged 65 years or older who participated in the Cardiovascular Health Study between 1992 and 1994. By using multiple linear regression models, the authors found that after adjustment for age, gender, and stroke history, Center for Epidemiologic Studies Depression Scale scores were independently associated with non-basal-ganglia lesions (p = 0.04) but were not independently associated with basal ganglia lesions (p = 0.11). When measures of physical disability and cognitive impairment were added to the models, these measures displaced MRI-identified infarcts in their association with depressive symptoms. In additional models, hemispheric location and size of the basal ganglia lesion were found to have no relation to depression levels. These results suggest that the functional consequences of cerebrovascular disease may be the causal pathway by which basal ganglia and non-basal-ganglia lesions are associated with depressive symptomatology. Am J Epidemiol 1999;150:919-29.
Major depression afflicts an estimated 1-2 percent of older adults who live in the community, and another 10 percent show symptoms of depression (1) . Despite the frequency of this condition, the causes of late-life depression are poorly understood. The few studies that have examined late-life depression have not found any strong evidence to suggest a genetic predisposition or alteration in psychosocial factors as the etiology (2) (3) (4) . However, there is evidence that certain diseases may be associated with depression, including stroke.
Imaging studies on selected depressed older patients have shown that a high proportion of them have basal ganglia lesions (5, 6) . Studies on poststroke depression suggest that the relation between basal ganglia lesions and depression is independent of physical and cognitive impairments (7, 8) . Specific mechanisms hypothesized to link basal ganglia lesions and depression are based on the unique anatomic position of the basal ganglia and its role as a modulator of the limbic system (9) . Direct injury to the midbrain monoamine neurons or disruption of their cortical projections is thought to affect mood by causing neurochemical changes (10) . Thus, it is thought that an organic origin of late-life depression has been supported in these stroke studies. Despite these findings, previous studies examining the relation between basal ganglia lesions and depression have had a number of limitations. These studies evaluated, fairly exclusively, small numbers of patients with a history of stroke and/or from neurologic and psychiatric centers, and there was a lack of standardized imaging protocols and insufficient information on potentially confounding risk factors. Furthermore, the potential roles of basal ganglia and non-basal-ganglia lesions in depression among community-dwelling older adults were not delineated, although hypotheses have centered specifically on basal ganglia lesions as the basis for depression in stroke.
The Cardiovascular Health Study recently reported that 36 percent of community-dwelling older adults 919 920 Sato et al.
showed evidence of infarcts on magnetic resonance imaging (MRI) (11) , with the majority being "silent" strokes. Sixty-six percent of the lesions were located in the basal ganglia area. Thus, these lesions are common. However, the clinical correlates of these MRI infarcts are unknown.
To further evaluate the association of basal ganglia and non-basal-ganglia lesions with depression, we conducted a cross-sectional study within the Cardiovascular Health Study, in which we assessed both MRI-identified lesions and the possible functional consequences of stroke that could in themselves be risk factors for depression. As part of the standardized clinical evaluation, 3,658 men and women received a cranial MRI examination. Systematic evaluation of a large number of MRI scans, combined with data on depressive symptomatology and cognitive and functional status in this community-dwelling cohort, enabled us to examine the links between MRI infarcts, physical and cognitive function, and depressive symptoms.
MATERIALS AND METHODS

Study population
The Cardiovascular Health Study is a populationbased, prospective observational study designed to evaluate risk factors for coronary heart disease and stroke in community-dwelling persons aged 65 years or older. The original study cohort consisted of 5,201 men and women recruited from a random sample of 1989-1990 US Health Care Financing Administration Medicare eligibility lists from four communities across the United States: Forsyth County, North Carolina; Sacramento County, California; Washington County, Maryland; and Pittsburgh (Allegheny County), Pennsylvania. Between 1992 and 1993, an additional 687 African American participants were recruited from the centers in Pennsylvania, California, and North Carolina, which brought the total study cohort to 5,888 subjects. Details regarding the study design and characteristics of the original Cardiovascular Health Study cohort have been published elsewhere (12) .
All eligible participants had to be aged 65 years or older, able to give informed consent, and able to respond to questions without a proxy. Potential participants who were wheelchair bound at home, institutionalized, or undergoing cancer treatment at baseline were excluded. Among the eligible participants, 58 percent agreed to enroll in the study and undergo baseline evaluation. Participants who enrolled in the study were more likely than nonparticipants to be younger, more educated, and married (12, 13) .
Measurements
Baseline evaluation and subsequent follow-up visits included standardized assessments of cognitive function, affective state, physical function, general health, and personal history. Depressive symptomatology was evaluated by using the shortened version of the Center for Epidemiologic Studies Depression Scale (CES-D) (14) , a widely used, self-report measure of depressive symptoms in community populations during the past week. Previous studies that used the CES-D demonstrated high internal consistency, reliability across diverse populations, and good correlation with other depression scales (15) . Each question was scored on a scale of 0-3 points, for a maximum of 30 points. On the CES-D, higher scores indicate higher frequencies of depressive symptoms.
The Modified Mini-Mental State (3MS) Examination and the Digit-Symbol Substitution Test were used to measure cognitive function. The 3MS expands the original 11-item Mini-Mental State Examination (16) and evaluates, on an objective scale of 0-100, a broader array of cognitive functions and a wider range of difficulty levels (17) . It includes tests of orientation, registration, attention, calculation, recall, language, and visual-spatial skills. The Digit-Symbol Substitution Test involves indicating a symbol associated with a particular digit by using a code table at the top of the examination sheet (18) . This test requires response speed, visual-spatial skills, and sustained attention; scores have no upper limits.
Physical disability was assessed by participants' self-report of difficulty in performing activities of daily living (ADL) and instrumental activities of daily living (IADL) tasks. In the present study, a modified version of the National Health Interview Survey supplement on aging questionnaire was used to evaluate ADL and IADL difficulty (19) . ADL assesses physical self-maintenance function in the following six areas: bathing, dressing, toileting, locomotion, continence, and feeding (20) . IADL assesses more complex everyday function in the following six areas: using the telephone, shopping, preparing food, performing light household work, performing heavy household work, and handling finances (21) .
Hypertension status was determined during the clinic visit by taking seated blood pressure measurements with a Hawksley random zero sphygmomanometer (model 7076; Hawksley and Sons Limited, Sussex, England) following a standardized protocol and by ascertaining antihypertensive medication use. In addition, demographic characteristics, social support (22) , and number of chronic diseases (self-report of physician diagnosis of any heart disease, cerebrovascular disease, hypertension, or pulmonary dis-ease; self-report of cancer or arthritis) were considered. To validate self-report of any cardiovascular disease, a morbidity and mortality classification committee followed standardized methods and reviewed medical records and clinical adjudication (23) .
MRI definition and grading
As part of the extended Cardiovascular Health Study follow-up protocol, all members of the cohort were invited to have cranial MRI scans during year 5 or 6 of the study (24, 25) . Study participants who had no contraindications to MRI scanning and were able to tolerate the procedure underwent the standardized imaging protocol. Contraindications included having metallic or electrical implants.
The MRI scans were performed by using 1.5 T scanners at three field centers and a 0.35 T instrument at the fourth field center (25) . Midline sagittal images were used to identify the anterior commissure-posterior commissure line along which subsequent oblique axial scans were aligned. By using a double spin echo technique, spin density and T2 weighted (3,000, 30/90, 0.5 or 1 (TR, TE, NEX)) images were obtained. By using a single spin echo technique, Tl weighted (500, 20, 1 or 2) images were also obtained. All images were oblique axial scans, extending from the vertex to the foramen magnum. For both the Tl and T2 weighted images, a series of sections 5 mm thick with no interslice gaps were obtained in the axial plane.
MRI infarcts were defined as focal, nonmass lesions with a vascular pattern that were hyperintense to gray matter on both spin density and T2 weighted images and were 3 mm or larger (11) . Location of the MRI infarcts was classified as one or more of 23 regions defined by gross anatomic location and vascular territory. For our study, basal ganglia included the caudate nucleus, lentiform nucleus, internal capsule, and thalamus. Lesion size was determined by using electronic cursor methods. The maximum lesion dimension was recorded as the larger of the anterior-to-posterior or right-to-left measurements. To take into account those persons who had more than one basal ganglia lesion, the maximum dimensions of all basal ganglia lesions were summed to provide an overall size. In addition, white matter grade and global brain atrophy, as reflected by ventricle and sulcal size, were graded according to predefined visual standards. White matter grade was assessed by grading the extent of increased white matter signal intensity on the spin density images in the periventricular and subcortical white matter area. The grading scale contains 10 points from 0 to 9. A higher score indicates a higher white matter grade or larger ventricles or sulci (11, 26) .
The MRI scans were reviewed by trained readers blinded to clinical data. These readers included board certified radiologists with subspecialty training in neuroimaging as well as a proficient neuroimaging technologist. All readers underwent an MRI interpretation training course specifically designed for the Cardiovascular Health Study. For MRI infarcts of >3 mm, the kappa statistics were 0.59 and 0.63 for interrater reliability and intrarater reliability, respectively (11) .
Data analysis
A cross-sectional study design was used to investigate the association between depressive symptomatology and MRI infarcts in both the basal ganglia and non-basal-ganglia regions. Since the MRI scans were conducted over a period of 3 years, the CES-D score and other non-MRI variables that were evaluated for each person were selected from the annual examina-. tion just preceding but closest in time to the MRI scan conducted for that person. Excluded from the analysis were participants with missing CES-D scores (n = 9), poor-quality scans (n -51), incorrect MRI protocols (n = 211), and incomplete MRI data sets (n = 99). For the analysis, the cohort was subdivided into the following four groups: group 1, no MRI infarct; group 2, MRI infarcts in the basal ganglia region only; group 3, MRI infarcts in the non-basal-ganglia region only; and group 4, MRI infarcts in both the basal ganglia and non-basal-ganglia regions.
The data were first summarized with descriptive statistics by using analysis of variance for continuous measures and the chi-square test for categorical data. The second phase of the analysis examined the bivariate associations of participants' medical, functional, and demographic variables with both MRI infarcts and depression on the basis of a priori hypotheses. Once bivariate analyses identified the significant variables, the independent association of basal ganglia and nonbasal-ganglia lesions with CES-D score was determined with multiple linear regression models. A forward sequential selection was performed by entering all variables associated in the bivariate analyses with both basal ganglia and non-basal-ganglia lesions and CES-D score. Dummy variables were used to enter lesion site. Additionally, to assess the potential impact of selection bias, each variable from the final model was removed one at a time, and the remaining model was reestimated to determine if the regression coefficient and significance level changed.
Because distribution of the CES-D score was highly skewed, a square root transformation was performed to normalize the score. Similarly, the size of the basal ganglia lesions was transformed by the natural loga-rithm to achieve normality. We also centralized the mean on all continuous variables to make the intercept readily interpretable. Thus, the intercept would be interpreted as the average square root of the CES-D score for the Cardiovascular Health Study cohort based on the variables provided in the regression model. Statistical Software for Social Sciences (SPSS) for Microsoft Windows was used for the analysis (27) .
RESULTS
Of the 5,888 members of the Cardiovascular Health Study cohort, 3,658 (62 percent) completed the cranial MRI examination successfully. Among the 2,230 remaining people, 2 percent died prior to MRI examination, 19 percent had contraindications to having an MRI scan performed, 33 percent attempted but were unable to complete MRI imaging, and 46 percent refused to participate. A comparison of selected characteristics between participants who completed the MRI examination and those who did not have the examination is shown in table 1. Participants who completed MRI scanning were significantly younger, were more functionally able, had a lower prevalence of hypertension, and had less depressive symptomatology according to CES-D score.
After participants with missing CES-D scores and missing or poor-quality MRI data were excluded, 3,371 subjects (57 percent) from the total Cardiovascular Health Study cohort were included in the present study. Their characteristics at baseline are presented in tables 2 and 3, stratified by the presence and location of MRI infarcts. In the univariate analysis, the group with no lesions was significantly younger, more functionally able, and generally healthier than the three groups with lesions. Among those with only one type of lesion, white matter grade was significantly higher in subjects with basal ganglia lesions, while subjects with non-basal-ganglia lesions had more physician-confirmed history of stroke. Otherwise, the two groups' characteristics were similar. Participants with both types of lesions had the worst functional status, more MRI abnormalities, and a higher prevalence of hypertension compared with the remaining three groups. Table 4 displays the crude estimated risks of having an MRI infarct in the basal ganglia and/or non-basalganglia regions, compared with those without any lesions, in relation to potentially associated characteristics. Increasing age, hypertension, history of stroke or transient ischemic attack, impaired cognition, greater brain atrophy, and higher white matter grade § Borderline significance between MRI infarct in non-BG and MRI infarct in both types of lesions groups (p= 0.066); significant differences in the remaining other combination of two groups (p < 0.001). % Mean number of difficulties in performing ADL or instrumental ADL tasks (0-6 scale). § The mean describes the degree of white matter signal intensity or brain atrophy (0-9 scale). were associated with having an MRI infarct in the basal ganglia and/or the nonbasal ganglia. ADL or IADL difficulty was associated with MRI infarct in the basal ganglia and the nonbasal ganglia. Participants with both types of lesions had risk patterns similar to those for the other two groups. ADL difficulties were much more strongly associated with the presence of lesions in both the basal ganglia and non-basal-ganglia areas (odds ratio = 3.06) compared with the risks for persons with lesions in just one area (odds ratios = 1.36 and 1.57, respectively; 95 percent confidence limits did not include 1 for any of these associations).
We next evaluated the association of depressive symptomatology, as measured by CES-D scores, with potential confounders. Results of the bivariate analyses with CES-D score as an outcome and the various factors as the exposure are presented in table 5. Depressive symptomatology was associated with poor functional status, female gender, older age, and race other than White. Among the MRI findings, white matter grade, ventricular atrophy, and the presence of any MRI lesion were significantly associated with depressive symptoms. A history of stroke or transient ischemic attack as well as hypertension also were associated with depressive symptomatology.
Finally, we evaluated the characteristics that were independently associated with CES-D scores. The results of six different multiple linear regression models, considered sequentially, are shown in table 6. Basal ganglia lesions were not associated with CES-D Interestingly, however, the association of white matter grade itself with depression levels lost significance in subsequent models when variables reflecting distal consequences of cerebrovascular disease were entered: impairments in cognitive and physical function. In model 5, MRI infarcts, whether in the basal ganglia or non-basal-ganglia regions, were not associated with depressive symptomatology when adjustments were made for measures of physical and cognitive function and for white matter grade. Difficulty in performing one or more IADL tasks was the variable most strongly associated with depression levels. ADL difficulty, 3MS score, and Digit-Symbol Substitution Test score all were independently significant predictors of CES-D scores, even though all of these functional measurements in our study were highly correlated. Age was not related to depression levels after adjustment for functional measures, while being female remained associated.
In model 6, we also adjusted for factors that other studies have associated with depressive symptomatology; income, social support, and number of chronic diseases were each independently associated with depressive symptomatology, but marital status was not. After adjustment for these potential confounders, depressive symptomatology remained associated with difficulty in performing IADL and ADL tasks and with 3MS score. A separate logistic regression model dichotomizing the CES-D score (<8 vs. >8) led to similar results.
We also examined the association of any MRI infarct with depressive symptomatology. The presence of any MRI infarct was associated with depressive symptomatology (p = 0.02, data not shown) after adjustment for age, gender, and history of stroke or transient ischemic attack; however, having any MRI infarct was no longer associated after adjustment for the variables in model 6 (p = 0.64).
We performed a similar multiple linear regression analysis to assess the association of size and laterality of basal ganglia lesions with CES-D score. The analyses were restricted to the 798 participants who had basal ganglia lesions. No association was found between size or hemispheric location of the basal ganglia lesions and levels of depressive symptoms (p = 0.19 for size, p = 0.82 for laterality). As was suggested in the multivariate model with the entire cohort, difficulty in performing IADL tasks was again highly associated with depression levels {p < 0.001 in both models) in this subset.
DISCUSSION
The Cardiovascular Health Study provides a unique opportunity to examine the association between MRI infarcts and depressive symptomatology in a large sample of community-dwelling older adults, while also considering function and other characteristics. When used to detect subcortical changes, MRI scans have been shown to be more sensitive than computerized tomography, which was the predominant form of assessment used in previous studies for patients with clinical stroke.
The central finding from this population-based cross-sectional study of community-dwelling older adults was that non-basal-ganglia lesions, compared with basal ganglia lesions, appear to be more strongly associated with depressive symptoms after adjustment for age, gender, and history of stroke or transient ischemic attack, although the confidence intervals overlapped. However, neither type of lesion was associated with depressive symptomatology after adjustment for deficits in cognitive and physical function. Impaired cognitive and physical function, versus MRI-identified anatomic lesions in the brain, emerged as the single most significant factor associated with depressive symptoms. Our findings are consistent with the interpretation that functional deficits may be the causal pathway by which MRI infarcts are associated with depressive symptoms. Alternatively, the lesions that affect cognition and function most severely are selectively associated with depressive symptoms. Among the functional measures, IADL difficulty independently exhibited the strongest association, presumably because of the complex sensorimotor and cognitive coordination required to complete IADL tasks (28) . Ultimately, however, interpretation of these results cannot distinguish depressive symptoms that occur as a simple reaction to functional loss from lesions organically severe or anatomically specific enough to cause functional loss, thus leading to depressive symptoms.
The results from this study are quite contrary to what the literature has suggested is a direct and causal relation between basal ganglia lesions and depression. The discrepancy may stem from a number of factors. Previous studies used a case-control design with small sample sizes, in which clinically depressed and nondepressed subjects were compared (5, 6) . These patients presented with severe clinical depression that required electroconvulsive therapy or hospitalization. Therefore, these studies had a greater selection bias than is present in the Cardiovascular Health Study.
Other studies looked specifically at poststroke depression in relation to lesion site (7, 8, 29) . The Cardiovascular Health Study population differs from the patients in the poststroke depression studies in several ways. First, participants are community dwelling and have a broad range of depressive symptomatology rather than clinically manifest depression. Second, most Cardiovascular Health Study participants with MRI infarcts do not have a history of clinical stroke (11) . Given the finding from model 2 (table 6) of the association of non-basal-ganglia lesions with CES-D score, these supposedly "silent" lesions may actually impact affective state to some degree. Finally, poststroke depression studies were generally conducted within a short time frame after patients had their strokes, whereas Cardiovascular Health Study participants could have had their strokes at any time in the past. Given this difference in timeframe, the impact could be to weaken the association found here and/or selective association with residual function as a result of brain lesions. Thus, the results from this study must be interpreted within the context of a community population rather than selected hospital patients. Our results should be more generalizable to the noninstitutionalized population of older adults.
Among the demographic variables, female gender and low income were significantly associated with increased numbers of depressive symptoms. The crude association between age and depressive symptoms disappeared after adjustment for functional status and gender. This finding is consistent with the study by Blazer et al. (30) .
The strong association between white matter grade and basal ganglia lesions in comparison to non-basalganglia lesions is of interest, since white matter abnormalities and basal ganglia lesions are likely to result from injuries to the long, penetrating, end arteries in the brain (31) . Moody et al. (32) demonstrated similar microscopic white matter and basal ganglia arteriolar changes associated with ischemic neuronal and white matter changes. This "small vessel" pathology is distinct from large vessel atherosclerosis and has been found in conjunction with MRI findings similar to ours regarding infarcts and white matter grade. It is likely that MRI infarcts in the basal ganglia and white matter grade are a consequence of the same pathophysiologic process but occur in different neuronal substrates. In addition, Longstreth et al. (31) reported an association of white matter grade with impaired cognitive and lower extremity function. If white matter grade and basal ganglia lesions represent similar biologic processes, associations of depression with basal ganglia lesions in prior studies could potentially be a result of confounding. Regardless, preventing small vessel disease may have wider clinical implications that are related to functional ability and other manifestations unknown at the present time.
The major limitation of our study is the potential for selection bias within this population-based study. Although the Cardiovascular Health Study provides data on a population-based sample of communitydwelling older adults in four US communities, participants who completed the MRI portion of the study generally represented the healthier portion of the cohort. Conversely, those persons in the non-MRI group had higher numbers of depressive symptoms, had more functional impairment, and were older. All of these factors were shown to be associated with basal ganglia and non-basal-ganglia lesions in the present study. The fact that a substantial portion of the cohort (38 percent) either could not undergo or refused cranial MRI may have biased our results toward the conservative or null findings, which leaves the question of whether different results would have been obtained if the non-MRI group had participated. Our analysis selectively excluding factors that were distributed differently between the MRI and non-MRI groups showed few differences in the regression estimates or significance levels. This finding leads us to believe that inclusion of the non-MRI group would not have changed the results substantially.
Another methodological question concerning the present study is whether misclassification associated with the outcome assessment may have occurred because an abbreviated version of the full CES-D questionnaire was used. However, since Shrout et al. (33) found that reducing the screening scale to as little as the five-item CES-D scale resulted in a similar sensitivity and specificity compared with the full 20-item CES-D scale, misclassification as a result of reducing the CES-D scale should have been minimal.
Another potential limitation is that because the CES-D scale assesses depressive symptoms on the basis of the past week's experience only, it is not possible to differentiate between persons who truly had depressive symptoms and those who just had an unpleasant week by using such a screening methodology. The CES-D was designed to assess depressive symptoms for research purposes; it was never meant to be used as a diagnostic measure (15) . However, Parikh et al. (34) reported a sensitivity of 86 percent and a specificity of 90 percent when the full CES-D scale was used to identify clinical depression in 80 patients following stroke. Since the validity and reliability of the CES-D score has been extensively evaluated as a screening tool in community surveys, high correlation between CES-D score and clinical diagnosis is more likely.
The final limitation concerns the cross-sectional nature of this evaluation. The prevalence of poststroke depression, whether major or minor, tends to rise as the time from the stroke event increases and then to resolve within 2 to 3 years in most cases (35, 36) . Therefore, the present study design may have underestimated real associations if the depressive episode occurred too long ago or if the subjects were in the acute stage of stroke. These questions will be addressed further when a follow-up MRI examination is performed. The cross-sectional nature of the study also limits the causal inference because temporality could not be established definitively. Although the idea cannot be rejected that depressive symptoms could be caused by neurochemical changes as a result of MRI infarct, depressive symptoms occurring as a reaction to functional limitations is plausible. The present data suggest that in the absence of MRI infarct, functional impairment is independently associated with depressive symptomatology. Given that MRI infarcts are permanent, functional impairment could be in the causal pathway leading to depressive symptomatology.
Despite limitations, the Cardiovascular Health Study has the major advantage of including a large populationbased community sample of older adults with comprehensive data on brain lesions and potentially associated characteristics. The sample size for the present study was at least 10 times larger than that of any reports published previously. Misclassification of lesion type or size should have been minimized by a protocol-defined review of all MRI scans and the exclusion of poorquality scans. Response bias was highly unlikely since all data were collected in a standardized fashion.
The R 2 values indicate that these multivariate models explain only 18 percent of the variance in the levels of depressive symptoms, at best. This value is similar to one from a study examining the relation between old age and CES-D scores (30) . Factors examined in this study that were reported to independently influence depressive symptoms in older adults included number of chronic illnesses, social support network, and income status (30, 37) . The results from this study attest to the heterogeneous risk factors associated with late-life depression.
In summary, our study of community-dwelling older adults did not find an independent association between basal ganglia lesions or any other MRI infarcts and depressive symptoms after adjustment for physical and cognitive function. However, the latter were independently associated with depressive symptomatology. Results suggest that the functional consequences of cerebrovascular disease may be part of the causal pathway by which basal ganglia and non-basal-ganglia lesions are associated with depressive symptomatology. Alternatively, it may be that the lesions causing such impairments are related to depressive symptoms. Further investigation should consist of prospective studies that examine the complex interplay between basal ganglia lesions, functional impairment, and other risk factors unexplored in the present study.
